looks like burn is averaging 1.6 mil per quarter and cash on hand is 2.7 million so realisticaly we'll need something in this quarter for certain. Im sure they wont let cash on hand fall to mich less than 1 million so that could be the trigger. After reading a bit about the roche deal with Aileron for stapled peptides i wonder if that technology could be applied to the phylomer peptides to increase stability. Not sure if Aileron has a library of their own peptides or if they work with others peptides. They certainly seem to all be moving in the same circles. If they can work on the peptides pyc have apparently identified maybe that improves the chances of a big deal. Certainly seems the potential payments offered to Aileron were even larger than phylogica's.
PYC Price at posting:
7.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)